drugset / Trial / NCT00066092
Pegfilgrastim PBPC Mobilization Study
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a randomized, double-blind, multi-center study to assess the safety and effectiveness of using a single subcutaneous (under the skin) injection of pegfilgrastim or daily subcutaneous injections of Filgrastim to mobilize stem cells for autologous transplantation in patients with Hodgkin's or non-Hodgkin's lymphoma.
Timeline
- Start
- 2003-04
- Primary completion
- 2004-03
- Completion
- 2004-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pegfilgrastim | Protein / enzyme biologic | 6 mg | Subcutaneous |
| Subject | Pegfilgrastim | Protein / enzyme biologic | 12 mg | Subcutaneous |
| Comparator | filgrastim | Protein / enzyme biologic | — | Subcutaneous |